20346441

Source:http://linkedlifedata.com/resource/pubmed/id/20346441

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0031740, umls-concept:C0205195, umls-concept:C0387288, umls-concept:C0796392, umls-concept:C1517572, umls-concept:C1656863
pubmed:issue	6
pubmed:dateCreated	2010-5-31
pubmed:abstractText	To evaluate the efficacy of photodynamic therapy with verteporfin with intravitreal bevacizumab for polypoidal choroidal vasculopathy.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20346441-21036213
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370500
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Photosensitizing Agents, http://linkedlifedata.com/resource/pubmed/chemical/Porphyrins, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab, http://linkedlifedata.com/resource/pubmed/chemical/verteporfin
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1879-1891
pubmed:author	pubmed-author:KishiShojiS, pubmed-author:MatsumotoHidetakaH, pubmed-author:MukaiRyoR, pubmed-author:SatoTakuT
pubmed:copyrightInfo	Copyright 2010 Elsevier Inc. All rights reserved.
pubmed:issnType	Electronic
pubmed:volume	149
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	947-954.e1
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:20346441-Aged, pubmed-meshheading:20346441-Aged, 80 and over, pubmed-meshheading:20346441-Angiogenesis Inhibitors, pubmed-meshheading:20346441-Antibodies, Monoclonal, pubmed-meshheading:20346441-Antibodies, Monoclonal, Humanized, pubmed-meshheading:20346441-Choroid, pubmed-meshheading:20346441-Choroid Diseases, pubmed-meshheading:20346441-Combined Modality Therapy, pubmed-meshheading:20346441-Female, pubmed-meshheading:20346441-Fluorescein Angiography, pubmed-meshheading:20346441-Humans, pubmed-meshheading:20346441-Injections, pubmed-meshheading:20346441-Male, pubmed-meshheading:20346441-Middle Aged, pubmed-meshheading:20346441-Peripheral Vascular Diseases, pubmed-meshheading:20346441-Photochemotherapy, pubmed-meshheading:20346441-Photosensitizing Agents, pubmed-meshheading:20346441-Porphyrins, pubmed-meshheading:20346441-Retreatment, pubmed-meshheading:20346441-Retrospective Studies, pubmed-meshheading:20346441-Tomography, Optical Coherence, pubmed-meshheading:20346441-Treatment Outcome, pubmed-meshheading:20346441-Vascular Endothelial Growth Factor A, pubmed-meshheading:20346441-Visual Acuity, pubmed-meshheading:20346441-Vitreous Body
pubmed:year	2010
pubmed:articleTitle	Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.
pubmed:affiliation	Department of Ophthalmology, Gunma University School of Medicine, Maebashi, Gunma, Japan. takusato@showa.gunma-u.ac.jp
pubmed:publicationType	Journal Article